Inceptionr LLC Trims Stake in HCA Healthcare, Inc. (NYSE:HCA)

Inceptionr LLC trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 38.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,395 shares of the company’s stock after selling 1,515 shares during the period. Inceptionr LLC’s holdings in HCA Healthcare were worth $719,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Whipplewood Advisors LLC purchased a new stake in HCA Healthcare in the 4th quarter worth $31,000. Legacy Investment Solutions LLC purchased a new stake in HCA Healthcare in the 3rd quarter worth $39,000. Activest Wealth Management increased its stake in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after buying an additional 125 shares in the last quarter. Capital Performance Advisors LLP purchased a new stake in HCA Healthcare in the 3rd quarter worth $41,000. Finally, Pinnacle Bancorp Inc. grew its position in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Bank of America cut their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Truist Financial lowered their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Morgan Stanley lowered their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Stock Up 2.6 %

Shares of NYSE HCA opened at $330.11 on Friday. The firm has a 50-day simple moving average of $316.70 and a two-hundred day simple moving average of $347.69. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a market cap of $81.98 billion, a P/E ratio of 15.03, a PEG ratio of 1.10 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the firm earned $5.90 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.87%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.